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ISSObjective: The objective was to evaluate community and healthcare worker
(HCW) values and preferences on key topics to inform the development of the
2013 WHO consolidated guidelines for antiretroviral therapy in low and middle
income countries.
Design: Cross-sectional e-survey and e-forum discussion; focus group discussions
(FGDs)
Methods: Data were collected on community perspectives regarding a range of
potential clinical and operational recommendations in the 2013 guidelines between
November 2012 and January 2013 through an e-survey (n¼1088) and e-forum
(n¼955). Additional FGDs were held with people living with HIV (PLHIV) in Malawi
and Uganda (n¼88) on antiretroviral therapy (ART) use among pregnant women. Two
surveys were also undertaken on similar topics covered in the e-survey for health care
workers caring for adults (n¼98) and children (n¼348).
Results: There were 1088 e-survey respondents from 117 countries: of whom
37.7% (298/791) were females, 49.9% (431/864) PLHIV, and 20.9% (174/831)
from low-income countries. The proportion of e-survey respondents who supported
raising the CD4þ T-cell threshold for ART initiation in adults from 350 to 500 cells/ml
was 51.0% (355/696), and regardless of CD4þ T-cell count for all pregnant females
89.8% (607/676), HIV serodiscordant partners 71.9% (486/676), and all children
on diagnosis of infection 47.4% (212/447). E-survey respondents strongly supported
discontinuing use of stavudine (72.7%, 416/572), task-shifting/sharing from doctors
to nurses (75.2%, 275/365) and from nurses to community health workers (71.1%,
261/367) as strategies to expand access to HIV testing, care, and treatment. Focus group
discussion respondents identified service capacity, and social and legal concerns
as key considerations influencing the decisions of women living with HIV to
continue ART after the risk of vertical transmission has passed. Key lessons learnt in
these consultations included the need for piloting and validation of questions;
sufficient time to adequately disseminate the survey; and consideration of using FGDs
and mobile phone technology to improve participation of people with limited internet
access.
Conclusion: Community participation in guideline development processes is important
to ensure that their perspectives are considered in the resulting recommendations.ippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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Antiretroviral therapy (ART) is a therapeutic and
preventive cornerstone of comprehensive efforts to
reduce HIV morbidity, mortality, and transmission.
Its scale up over the past decade has been possible through
the ownership, involvement, and action of people living
with HIV (PLHIV) and their communities [1,2].
In HIV program implementation, community partici-
patory approaches are important to ensure that
policies and interventions respond to the needs and
circumstances of people most at risk of or living with
HIV [3]. Participatory methodologies, like community
consultations, provide a platform for community voices
to be heard and ensure that new recommendations
and interventions are acceptable, safe, and accessible,
particularly to the most marginalized communities [4,5].
Involving affected communities has the potential to create
a sense of ownership of new interventions and programs
[6,7].
This is also applicable to the development of new
HIV prevention, treatment, and care guidelines, whose
recommendations affect communities living with or
affected by HIV. The practice of engaging affected
communities in the development of HIV-related policies
and guidelines was employed to inform the WHO’s 2010
guidelines on ART for adults and adolescents, and the
use of antiretrovirals (ARVs) for preventing vertical
transmission [8,9]. More recently, WHO convened
consultations in Harare and Bangkok that aimed to
collect views from community representatives on the
strategic use of ARVs [10,11].
The approach to developing WHO guidelines
WHO uses the Grading of Recommendations, Assess-
ment, Development and Evaluation (GRADE) system
during the guidelines development process [12]. This
approach emphasizes a structured, explicit, and transparent
process of rating the quality of evidence and strength of
recommendations. It also involves a critical review of the
evidence, usually comprising systematic reviews, random-
ized clinical trials, and observational studies, as appropriate.
As part of the GRADE process used to develop
recommendations for the 2013 consolidated guidelinespincott Williams & Wilkins. Unauthoon the use of antiretroviral drugs for treating and
preventing HIV infection (2013 Guidelines), the
guidelines development groups also considered the values
and preferences of communities and healthcare workers
(HCWs); potential implications on equity and human
rights; cost and cost–effectiveness; feasibility and barriers;
and overall benefits and harms of potential recommen-
dations [13]. To ascertain the perspectives of affected
communities regarding priority clinical, operational, and
programmatic issues, WHO commissioned the Inter-
national HIV/AIDS Alliance (Alliance) and the Global
Network of People Living with HIV (GNPþ) to conduct
a series of community consultations. WHO also
conducted an assessment of HCW values and preferences
[14,15].
This article highlights the key findings and lessons learnt
from these consultation processes. It also discusses the
implications of the findings in relation to the adaptation
and implementation of the 2013 Guidelines at the
country level, and suggests how to optimize community
engagement to inform future guidelines.Methods
These community consultations employed the following
participatory methodologies: e-survey, e-forum dis-
cussions, and thematic focus group discussions (FGDs).
These data were also evaluated with the findings from the
HCW surveys conducted by WHO.
E-survey
The e-survey consisted of 70 questions, delivered
using Survey Monkey (www.surveymonkey.com) in six
languages (English, French, Arabic, Chinese, Russian,
and Spanish). The questionnaire explored community
preferences regarding possible clinical recommendations
(e.g., which ARVs to use and when to initiate ART for
adults, adolescents, pregnant and breastfeeding women,
and children), as well as operational and programmatic
considerations of ART delivery. Questions were
developed based on key topics to be addressed in the
2013 Guidelines, together with existing guidance on
the topic and potential scenarios for new recommen-
dations, provided by the WHO Secretariat. Each e-surveyrized reproduction of this article is prohibited.
Community and Service provider views to inform WHO ARV guidelines Hsieh et al. S207section contained a summary of the current WHO
guidance on the topic, if any, and possible new
recommendations. The questions were revised and
validated with input from a Community Consultation
Working Group that consisted of representatives from
communities of PLHIV, key populations, and service
providers (see Acknowledgements). All questions were
optional, excluding consent to participate and age.
For 28 questions, respondents were able to choose
multiple responses from the options presented. For
20 questions, respondents rated the importance of, or
their agreement with, particular options provided to the
question on a Likert scale from ‘not important/strongly
disagree’ to ‘very important/strongly agree’. For eight
questions, respondents ranked the options provided in
numerical order, from most important to least important.
Responses were obtained over a 6-week period between
November and December 2012.
E-forum
The e-forum discussion, conducted in five languages
(Arabic, English, French, Russian, and Spanish), explored
selected topics and early draft recommendations by
probing for further discussion on aspects that could not be
covered comprehensively by the e-survey questions. A
one week period was allocated to each of the four main
topics between December 2012 and January 2013.
E-forum facilitators were responsible for posting the
questions, rephrasing ambiguous questions to stimulate
discussion, and posting a thematic summary of the
main points at the end of each week. The facilitators
summarized all discussions after all e-forum topics were
discussed.
Focus group discussions
FGDs conducted by GNPþ and the International
Community of Women Living with HIV (ICW) in
Malawi, using Chichewa (with simultaneous translation
into English), and in Uganda, using English (with
translation into Luganda as needed), explored the
perspectives and experiences of women and their
partners living with or affected by HIV regarding the
offer of lifelong ART to pregnant or breast-
feeding women (Option Bþ) to prevent vertical
transmission of HIV. FGDs were held over two weeks
in November 2012.
Healthcare worker surveys on pediatric and
adult care
Two cross-sectional e-surveys, conducted in English,
were developed by WHO for HCWs providing pediatric
or adult ART to elicit their perspectives on potential
policy changes. Responses were collected over three
weeks in November 2012.
Participant recruitment
Invitations to communities and civil society to participate
in the e-survey and e-forum were disseminated throughCopyright © Lippincott Williams & Wilkins. Unautthe GNPþ website, GNPþ Facebook page, national
and regional networks of PLHIV, and other key
populations, and the Alliance website, intranet, and
network of local organizations, with a request to further
disseminate widely to nongovernmental organizations
(NGOs), community-based organizations (CBOs),
and community-level contacts. WHO’s HIV/AIDS
department also circulated an announcement through
its website and partner networks. Further messages
were posted on global, regional, and national list
servers used by PLHIV communities, NGOs and CBOs
concerned with HIV care and treatment (e.g., AID-
SPortal website, GHDonline forum, E-drug online
forum, British Medical Journal blog pages, among others).
FGD participants were recruited by national networks of
women living with HIV in Malawi and Uganda. The
HCW surveys were distributed through major ART
provider agencies and networks: African Network for
AIDS Physicians (ANEPA), International Centre for
AIDS Care and Treatment Programs (ICAP), Inter-
national Epidemiologic Databases to Evaluate AIDS
(IeDEA), and Me´decins Sans Frontie`res (MSF) for the
adult HCW survey; and African Network for Care
of Children Affected by HIV/AIDS (ANECCA),
Clinton Health Access Initiative (CHAI), and Paediatric
European Network for Treatment of AIDS (PENTA-ID)
for the pediatrics HCW survey. All e-survey, e-forum,
and FGD participants provided voluntary written
consent.
Analysis
E-survey responses were analyzed using SPSS
(version 21; IBM). Descriptive analysis was performed
of self-identified gender, HIV status, key population
membership, and income status of respondents’ country
of origin. For questions that required selecting a
degree of importance/agreement to options, numerical
values were assigned to responses (2 for very
unimportant/strongly disagree; 0 for neither agree nor
disagree/important nor unimportant; þ2 for very
important/strongly agree). For questions that required
respondents to rank the importance of options,
numerical values were assigned from 1 for the least
important up to the highest number of options avail-
able to be selected. Using these numerical values, the
arithmetic means for each option were calculated and
resulted in the comparative ratings of options for these
questions. In addition, Pearson’s x2 test and Welch’s t-test
were performed to investigate differences between
subgroups. E-forum content was analyzed by identifying
common themes and areas of consensus in each
discussion [16]. FGDs were moderated by a facilitator,
who asked open-ended questions and used probes,
recorded, transcribed, and thematically analyzed [16].
For the HCW surveys, quantitative data were analyzed
using Microsoft Excel 2010, and a thematic analysis was
undertaken for free text responses [16].horized reproduction of this article is prohibited.
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Characteristics of respondents
Table 1 summarizes the key demographic characteristics
of the e-survey, e-forum, and FGD respondents.
E-survey
Overall, 1088 people from 117 countries responded to
the e-survey, including 37.7% (298/791) women, 49.9%
(431/864) PLHIV, 20.9% (174/831) from low-incomepyright © Lippincott Williams & Wilkins. Unautho









HIV status 864 (79.2)
PLHIV 431 (49.9)
HIV-negative 406 (47.0)
Do not know 27 (3.1)
Key populations 489 (44.9)
Pregnant womena 80 (16.4)
Young people (20–24 years old) 61 (12.5)
Adolescents (10–19 years old) 14 (2.8)
MSM 220 (45)
Transgender 14 (2.8)
People who inject drugs 28 (5.8)
Sex workers 30 (6.1)
Refugees/migrants 42 (8.6)
Age 880 (80.9)
10–19 years old 10 (1.1)
20–24 years old 53 (6.1)
25–34 years old 264 (30)
35–44 years old 280 (31.8)
45–54 years old 189 (21.5)
55–64 years old 67 (7.6)
65þ years old 17 (1.9)











Low-income countries included Kenya (n¼35), Zimbabwe (n¼26), countri
Malawi, Myanmar, Nepal, Rwanda, Tanzania, Uganda), and countries wi
Gambia, Guinea, Guinea-Bissau, Haiti, Kyrgyz Republic, Liberia, Mali, M
included China (n¼146), India (n¼23), Moldova (n¼16), Nigeria (n¼62
with n between 6–15 (Argentina, Cameroon, Mexico, Morocco, Namibia,
countries with n5 (Armenia, Algeria, Anguilla, Belize, Bhutan, Bolivia, Bo
the Congo, Costa Rica, Coˆte d’Ivoire, Cuba, Djibouti, Dominican Republic,
Lebanon, Lithuania, Malaysia, Mauritius, Pakistan, Paraguay, Peru, Roman
Suriname, Syrian Arab Republic, Uruguay, Uzbekistan, Venezuela, Vietna
United States (n¼74), countries with n between 6–15 (Australia, Canada, N
Belgium, Bermuda, Brunei, Czech Republic, Denmark, France, Germany, G
Singapore, Spain, Sweden, Taiwan, Trinidad and Tobago).
aA woman who is pregnant or has been pregnant in the last 2 years, or w
bWorld Bank Country Income Status definitions were used.countries, and 58.9% (458/831) from middle-income
countries, based on self-identification.
E-forum
There were 955 subscribers who posted 155 responses.
No demographic information was obtained from
e-forum participants.
Focus group discussions
Of the 88 participants, there were 76 women living


























es with n between 6–15 (Democratic Republic of the Congo, Ethiopia,
th n5 (Bangladesh, Benin, Burkina Faso, Burundi, Cambodia, The
ozambique, Niger, Sierra Leone, Togo). Middle-income countries
), South Africa (n¼29), Ukraine (n¼28), Zambia (n¼18), countries
Philippines, Russian Federation, Senegal, Swaziland, Thailand), and
snia andHerzegovina, Botswana, Brazil, Chile, Colombia, Republic of
Ecuador, Fiji, Georgia, Ghana, Indonesia, Iran, Jamaica, Kazakhstan,
ia, Samoa, Serbia, Seychelles, Sri Lanka, St. Kitts and Nevis, Sudan,
m). High-income countries included United Kingdom (n¼35) and
etherlands, Switzerland), and countries with n5 (Austria, Barbados,
reece, Hungary, Ireland, Israel, Netherlands Antilles, Norway, Poland,
ho is planning to have a child in the next 2 years.
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sessions that included women living with HIV from
rural settings (n¼ 10), those from urban settings (n¼ 11),
those who are Muslim (n¼ 9), or who had leadership
experience (n¼ 13). In Kampala, Uganda, 45 participants
were allocated to one of four group sessions that
included women living with HIV under 30 years of
age (n¼ 11), women living with HIV from rural settings
(n¼ 12), women living with HIV with leadership
experience (n¼ 12), and male partners of women living
with HIV (n¼ 10). Participants were grouped by these
characteristics to understand the different experiences
of those involved in decision-making or policy-making,
those from a religious minority, and male partners.
Healthcare worker surveys
The pediatric HCW survey had 348 respondents. The
majority (44.5%, 155/341) were from southern Africa,
east Africa (22.0%, 75/341), west or central Africa
(16.4%, 56/341), and south-east Asia (7.0%, 24/341).
Most respondents were pediatricians (37.9%, 128/338),
general physicians (29.3%, 99/338), or clinical officers
(9.5%, 32/338), providing care to children older than
2 years (87.7%, 292/333). The adult HCW survey had
98 respondents. The majority (46%) were from southern
or east Africa (32%).
Key findings
Table 2 summarizes the key areas covered in the e-survey
and e-forum. The relevant e-survey questions can be
found in the Web Appendix, http://links.lww.com/
QAD/A498.
When to start antiretroviral therapy?
Figure 1 shows e-survey respondent preferences regarding
when to start ART. Overall, 51.0% (355/696) of all
e-survey respondents supported starting adults and
adolescents on ART at a CD4þ T-cell count between
350 and 500 cells/ml or less. Only 9% of the adult HCWCopyright © Lippincott Williams & Wilkins. Unaut
Table 2. E-survey and e-forum topics covered.
E-survey topics E-forum topics
Use of ARVs for treatment and prevention
in adults and adolescents
Use of ARVs for trea
When to start
When to start – c
What treatment
Which ARVs – wh
How to deliver
TasP/PrEP – what
Use of ARVs in pregnant women Use of ARVs in child
When to start When to start – c
What treatment Which ARVs – pr
How to deliver How to deliver –
Use of ARVs in children Use of ARVs in preg
When to start Which ARV regim
What treatment Programmatic issues
How to deliver How to deliver –
Operational and service delivery issues Human rights in th
Programmatic decision-making issues Community involv
How to make the
ART, antiretroviral therapy; ARV, antiretroviral.survey respondents stated that earlier initiation should
not be considered before full coverage was reached at
350 cells/ml.
What antiretroviral therapy regimen to use for adults?
With earlier initiation, e-survey respondents were keen
to see increased access to simpler, more tolerable, and
effective ARVs, preferably as ‘once-daily’ dosing with a
single pill (77.9%, 493/633). The majority of the adult
HCW survey respondents agreed that once-daily regi-
mens were either critical (54%) or important (35%).
E-survey respondents who reported current use of
stavudine preferred not continuing with this medication
(72.7%, 416/572). However, the adult HCW survey
respondents held mixed views regarding the priority for
phasing out stavudine: users with side-effects (42%) were
the priority, followed by all users (27%).
Who should be offered antiretroviral therapy regardless
of CD4R T-cell count?
Figure 2 shows e-survey responses to the question, ‘which
people or populations living with HIV should be offered
ART regardless of CD4þ T-cell count? Support for ART
initiation in specific populations regardless of CD4þ
T-cell count among e-survey respondents was greatest for
PLHIV in serodiscordant couples (63.3%, 286/452), with
other groups, including PLHIV who are sex workers,
MSM, and people who inject drugs, ranging between
52.9 and 23.0%. The offer of lifelong ART to pregnant
women is addressed below. A third of e-survey
respondents (33.0%, 149/452) supported offering ART
to anyone living with HIV, regardless of CD4þ T-cell
count. There were no statistical differences according to
HIV or country income status. The adult HCW survey
respondents also supported offering ART to partners in
serodiscordant relationships (47%). E-forum contributors
reaffirmed that early ART could benefit individuals in
serodiscordant relationships or who also live with hepatitishorized reproduction of this article is prohibited.
tment and prevention in adults and adolescents
hanging the ART initiation threshold from 350 to 500 CD4þ cells/ml
at form of ARV (e.g., once-daily, co-blistering, etc.)
opportunities does TasP/PrEP offer to the HIV response
ren
hanging the ART initiation threshold
eferred regimen
challenges of pediatric ART enrolment
nant women
en to prevent vertical transmission
how to link with broader care for women; how to scale up access
e guidelines on ARVs for treatment and prevention
ement in country-level decision-making
decision-making process more inclusive, fair and transparent
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0% 10% 20% 30% 40% 50% 60%
When the CD4+ T-cell count is above 350 cells/µl but
below 500 cells
When they have co-infections (TB, hepatitis B or C) regardless of
CD4 count
When they are seriously ill, regardless of CD4+ T-cell count or WHO
guidelines
When they feel ready to start ART
When the doctor advises/makes a recommendation
When the CD4+ T-cell count is between 200 and 350 cells/µl
When they can be guaranteed access to an uninterrupted supply
of first-line ART
As soon as they are diagnosed with HIV
When the CD4+ T-cell count is between 100 and 200 cells/µl
When the CD4+ T-cell count is at or below 100 cells/µl
Proportion of respondents
All respondents
Fig. 1. When should people living with HIV be offered antiretroviral therapy? (nU696).B, and should be offered to key populations, such as
injecting drug users or men who have sex with men.
Potential challenges to offering antiretrovirals for
prevention, and essential actions to overcome them
E-survey respondents highlighted important challenges to
offering ARVs for prevention, including the difficulty
of adhering to ARTwhile feeling healthy (1.17 on a scale
of 2 to þ2 from strongly disagree to strongly agree);
sustainability of ART access (1.13); and criminalization
of key populations (1.19). PLHIV e-survey respondents
were particularly concerned that some public services
may use ARVs for prevention to ‘test and treat’ people
without respect for individual rights and choices (0.89).
To overcome these challenges, e-survey respondents
considered it important to use ARVs for prevention in





































































Fig. 2. Who should be offered antiretroviral therapy regardless oand community interventions (1.69 on a scale of 2 to 2
from least important to most important); to acknowledge
that the primary benefit of treatment is for the individual
and the secondary benefit is for prevention (1.67); and to
ensure that literacy related to use of ARVs for prevention
is strengthened (1.60). E-survey respondents frequently
called for ARVs for treatment and prevention programs
to use a human rights approach (1.47).
Preferences for lifelong antiretroviral therapy in
pregnant women
A majority of e-survey respondents agreed that pregnant
women should be offered ARTregardless of CD4þ T-cell
count (89.8%, 607/676) and strongly preferred Option
Bþ (described as ‘triple ARV treatment for all pregnant
women living with HIV regardless of CD4þ T-cell count
as soon as HIV diagnosis is confirmed and ART is










































f CD4R T-cell count? (nU452).
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regardless of infant feeding method’) (66.1%, 290/439;
versus 13.2% for Option A, 17.5% for Option B,
and 3.2% for none of the above), which correlates with
e-forum and FGD findings. A majority of the adult HCW
survey respondents (79%) agreed.
One e-forum respondent stated, ‘all countries should
move to Option Bþ if the resources are available . . .
However, cost, the burden of care, long-term adherence,
and toxicities are problem[s]. As a result, pregnant women
would choose the option themselves. All pregnant
women should be referred to an HIV physician who
could explain all options to the women.’
While recognizing many benefits associated with
Option Bþ, FGD participants also identified concerns,
such as the expectation that women must start ART as
soon as they received a diagnosis of infection, without
sufficient psychosocial and counseling support, and time
to think through the implications or prepare for disclosure
to partners. One female FGD respondent from Malawi
remarked, ‘Women have challenges because if they go out
of the hospital with medication, they can’t think of ways
to inform their husbands so they take [the medications]
behind their husband’s back. Some of them don’t take
their medication.’
Considerations of whether to continue When the risk
of vertical transmission had passed, e-survey respondents
identified uninterrupted access to first-line ARVs (1.79)
and ease of accessing ARVs (1.76) as among the most
important considerations in determining whether or
not women living with HIV should continue on
ART. Women living with HIV from the e-survey also
considered their CD4þ T-cell counts as an important
consideration (1.55). One female Ugandan FGD
respondent said, ‘After giving birth, I’ll stop that drug
because you know I was started on the drugs with pressure
just to protect my child,’ indicating that personal readiness
to continue lifelong treatment, as well as messaging, is
also critical.
Service capacity issues E-survey respondents identified
the following as important for the successful imple-
mentation of Option Bþ: ensuring that quality of care is
not compromised (1.89); linkage between sexual and
reproductive health services and HIV services (including
ART) (1.82); retention in postnatal ART care for mothers
(1.82); capacity of health facility-based services (1.81);
retention in postnatal ART care for children (1.81); and
the capacity of community-led services (1.71).
Social and legal considerations One Muslim Malawi
FGD participant cited an example of discrimination due
to her religion when seeking antenatal care: ‘[They said],
‘The way that you dress [as a Muslim woman], how couldCopyright © Lippincott Williams & Wilkins. Unautyou get infected?’ . . . It was a public hospital, so my
husband took me to a private hospital.’ Similarly, e-survey
respondents identified the following as important
challenges to overcome for the successful implementation
of Option Bþ: stigma and discrimination from
healthcare providers (1.68), family members (1.65), and
within the community (1.64); inequity (1.57); gender-
based violence (1.49); male involvement (1.48); HIV
criminalization (1.25); and forced sterilization (0.84).
Involvement of women living with HIV In addition to
verifying the e-survey results, FGD participants high-
lighted that communities should have an ongoing role
in decision-making, monitoring, and supporting the
implementation of Option Bþ. One female Ugandan
FGD respondent with leadership experience stated,
‘No women living with HIV of childbearing age were
consult[ed]. . .’ FGD respondents remarked that com-
munity participation improves understanding and support
in the community; builds active partnerships between
community, health ministry, and service providers;
and provides ongoing feedback to address issues and
strengthen programs. To achieve this, FGD respondents
felt that women living with HIV require support and
access to capacity-building opportunities. One female
Ugandan FGD respondent suggested, ‘If we involve
[young women living with HIV] in such trainings,
forums, workshops, especially in their clinics or train their
counsellors . . . by the time they get pregnant, they know
what to expect.’ (A fuller discussion of these consider-




When should children be offered antiretroviral
therapy?
Figure 3 shows e-survey preferences for what age
children should be offered ART regardless of their
CD4þ T-cell count. Nearly half of e-survey respondents
(47.4%, 212/447) agreed that children should initiate
ART immediately after a diagnosis of infection, although
it was unclear whether they preferred an age-specific cut-
off (e.g., children 5 years old). There were no statistical
differences by country income status (P> 0.05) or gender
(P> 0.05). Meanwhile, 64.2% (194/303) of the pediatric
HCW survey respondents thought that immediate
ART should be recommended beyond infancy, and
the majority (67.7%, 153/226) indicated 5 years old or
younger as the preferred option.
What antiretroviral therapy regimen to use for
children?
For children younger than 3 years, 51.4% (223/434) of
e-survey respondents preferred regimens with greater
effectiveness, such as syrup containing lopinavir/ritona-
vir, despite known storage and administration difficulties.horized reproduction of this article is prohibited.
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Fig. 3. When should children be offered antiretroviral therapy? (nU447).These findings were consistent with those from the
pediatric HCW survey, who viewed lopinavir/ritonavir
very favorably (31.1%, 87/279) or somewhat favorably
(21.1%, 59/279) [14]. For children older than 3 years,
36.6% of e-survey respondents (155/424) preferred
tenofovir/lamivudine/efavirenz as a first-line regimen.
Although 30.8% of the pediatric HCW survey respon-
dents (80/260) preferred the same regimen, more
pediatric HCW survey respondents (36.9%, 96/260)
preferred a zidovudine-based regimen [14]. The need
for toxicity monitoring was their main rationale for
deprioritizing tenofovir.
On a scale of 2 to þ2 from least to most important,
e-survey respondents noted that the need for toxicity
monitoring of tenofovir (1.70), official approval of
proposed medication (e.g., tenofovir) for use in young
children (1.40), once-daily dosing (1.58), and ease of
storage without refrigeration (1.55) are important
considerations for parents or caregivers, and can affect
children’s adherence to ART. As stigmatizing attitudes
or lack of support can prevent children from accessing
treatment, an e-forum participant suggested ‘building
the capacity of health workers in pediatric HIV and
offering treatment literacy education to parents’ as means
of mitigating this.
Operational and service delivery
Improving access, retention in care, and adhe-
rence Figure 4 demonstrates the barriers that must
be addressed to improve retention in HIV care. On a
scale of 1–6 from least to most important, e-survey
respondents identified access to ARVs (4.6 among
PLHIV) and HIV testing (4.2 among PLHIV) as among
the most challenging barriers that must be addressed
to improve retention. There were some statistical
differences (P< 0.05) according to HIV status. For
example, PLHIV identified healthcare provider attitudes
(4.1 among PLHIV, 3.5 among non-PLHIV) and age ofpyright © Lippincott Williams & Wilkins. Unauthoconsent for adolescents (3.8 among PLHIV, 2.3 among
non-PLHIV) as more challenging barriers, whereas those
not living with HIV regarded access to HIV testing (4.8),
linkage to care (4.2), and availability of ARVs in antenatal
clinics (4.4) as more important. Low-income country
respondents assigned greater importance to HIV testing
access, whereas middle-income country respondents
assigned lesser importance to the cost of childcare
during clinic visits (P< 0.05). This disparity provides
another reminder that the barriers actually identified by
PLHIV themselves should be prioritized to improve their
retention in care. ‘People who are still relatively well . . .
might not put adherence in its proper perspective. [A] lot
more rigorous patient education on adherence’ would be
required.’
Task-shifting/sharing and decentralization E-survey
respondents supported task-shifting/sharing from doctors
to nurses (75.0%) and from nurses to community health
workers (71.0%). However, they noted that nurses and
community health workers need to receive adequate
training, regular supervision and updating, and should
be allowed to provide HIV care and treatment services to
PLHIV who are stable and do not require a doctor’s
consultation. As this question referred only to the care
of PLHIV, respondents most likely answered this question
to mean care for adults, not children.
Role of communities
E-forum respondents discussed the importance of
community systems linkages with health systems, and
support for ART adherence, stigma reduction, and
advocacy. They identified community mobilization,
empowerment, and sensitization as requirements for
successfully supporting access to services for PLHIV
and other key populations, and addressing human rights
issues. Across e-forum discussions, communities were
seen as critical partners for civil society and governmentrized reproduction of this article is prohibited.








































































































































































































Fig. 4. Barriers that must be addressed to improve retention in HIV care (people living with HIV, PLHIVU431; non-
PLHIVU406).in advocating for the elimination of stigma and
discrimination; demanding and supporting inclusive,
fair, and transparent ART programs; holding leaders
to account; and supporting adherence to treatment.
E-forum respondents also emphasized the importance of
involving communities at all stages of developing and
implementing the 2013 guidelines. Echoing the results
of the Harare and Bangkok community consultations,
community respondents in these consultations high-
lighted the many roles communities are uniquely
positioned to play in service delivery, scale up of
interventions, operational research and evaluation, and
advocacy at local, national, and regional levels to increase
the effectiveness of efforts to provide access to HIV care
and ART for all who need it [17,18].Discussion
This consultation, based on different methodologies,
was one of the largest and most comprehensive global
community consultations on ARVuse undertaken to date
to inform a guidelines development process. As one of
the decision-making components of the GRADE
method for developing guideline recommendations,
the consultation findings informed some key recom-
mendations in the 2013 guidelines. Preliminary findings
were presented to the adult and adolescent, maternal and
child health, and programmatic guidelines developmentCopyright © Lippincott Williams & Wilkins. Unautgroups. Key community values and preferences con-
sidered by the Guidelines Development Groups included
the earlier offer of ART to all PLHIV; the immediate offer
of ART to certain groups (e.g., pregnant women using
Option Bþ and serodiscordant couples); the expansion of
the immediate start of pediatric treatment; the phase out
of stavudine; and task-shifting/sharing of HIV-related
services with nurses and community health workers.
Additionally, participants expressed the view that success-
ful implementation of the 2013 guidelines requires an
enabling environment in which the human rights of
PLHIVand key populations are protected and promoted;
stigma and discrimination are eliminated; gender inequal-
ities, poverty, and food insecurity are mitigated; and
integration and decentralization are prioritized through
appropriate task-shifting/sharing strategies. These data
were incorporated into the GRADE decision-making
process and contributed to the final recommendations.
Challenges and lessons learnt
The challenges experienced during this community
consultation process yielded valuable lessons that can help
optimize the role of communities in future consultations
for developing guidelines.
The need for internet access to participate in the e-survey
and e-forum limited the representativeness and general-
izability of the findings. Conducting consultations on the
ground (e.g., using FGDs or mobile phone technology),
particularly with underrepresented communities tohorized reproduction of this article is prohibited.
Co
S214 AIDS 2014, Vol 28 (Suppl 2)optimize stakeholder representation, could compensate
for the limitations of online consultations and regional
consultation meetings, and improve applicability and
relevance of the guidelines.
The e-forum responses during December 2012 were also
limited, possibly due to proximity to the December
holiday period. Ensuring appropriate timing for com-
munity consultations could prevent this problem.
The e-survey question structure presented some
challenges and limitations to the interpretation of
responses. The length of the e-survey and the technical
nature of some questions caused many respondents to skip
questions, which may introduce bias. This could be
addressed by shortening and simplifying the e-survey, or
by separating the sections into separate surveys and
sharing them with relevant communities to increase
accessibility by a wide and relevant range of respondents.
Increasing investment in consultations on the ground
could also improve relevance of the outcomes.
The e-survey questions using a Likert scale (i.e., strongly
agree/strongly disagree; most important/least important)
were subject to known limitations of rating scales and the
tendency for responses to support the statement. For
instance, the discriminatory value of a Likert scale is
dependent on a variety of factors, such as internal
structure of the questionnaire [19] and local context [20].
Likert scales are commonly associated with acquiescence
bias, which is a tendency to agree with statements,
independent of their content [21]. Additionally, there
is no consensus on the optimal number of response
alternatives in rating scales more generally [19]. In the
e-survey, weightings needed to be assigned by the analyst
rather than allowing respondents to rank the importance
or limit the number of options deemed ‘important’.
Additionally, the wording of some questions resulted in
ambiguous answers that are difficult to interpret with
certainty. No data or analysis, is, therefore offered for
these questions in this report.
The structure of e-survey questions differed in terms of
the range of options and possible selections. The ratings
calculated for one question are not comparable to the
ratings of another question if the question structures are
not the same. Working with consultation groups to assist
in refining and revising the questions could help to
sharpen the questionnaire. Further limiting the number
of options for selection by respondents could also prevent
these shortcomings.
The e-survey dataset also presented some challenges
and limitations. Respondents were permitted to skip
questions, and only small numbers of respondents
answered some of the questions (for reference, the total
number of respondents is noted for each questionpyright © Lippincott Williams & Wilkins. Unauthothroughout the report). Future surveys could be more
rigid, with no option to skip questions, in order to
prevent unequally sized datasets.
Incorrect data entry by some respondents invalidated
some answers (e.g., respondent identifying as both ‘male’
and ‘pregnant woman’). Designing the survey with more
question flows (e.g., gender-specific options for answers)
and a built-in validation check could minimize this.
Few respondents self-identified as members of specific
population groups (e.g., adolescents, over 65-year-olds,
transgender people), yielding results that did not have
sufficient sample sizes for reliable and accurate statistical
interpretation (for reference, the total number of
respondents self-identifying with specific populations is
noted for each question throughout the report). As noted
in the respondent demographics, some groups (e.g.,
transgender people) were underrepresented, whereas
others (e.g. MSMs) were overrepresented in the e-survey,
which may hinder generalizability of the findings.
However, FGDs engaging specific populations (e.g.,
pregnant and breastfeeding women) proved very useful
for focusing on specific issues and could be expanded to
other specific populations in the future. Directing
the survey to community key population networks and
groups could increase sample size and equitable repre-
sentation. Using a mixture of methods and triangulation
of data from different data sources (qualitative and
quantitative) could also supplement this data gap.
Additionally, future consultations employing multiple
methodologies could improve their comparative
value by collecting the same demographics data for
all participants.
Because of the above limitations, community responses
regarding key populations, such as sex workers or
injecting drug users, do not necessarily reflect the views
of key populations themselves. For some e-survey
questions regarding services provided to key populations,
answers may have been biased by respondents’ opinion of
the service rather than their opinion about a key
population. Alternatively, for some questions regarding
barriers to services, answers may have been biased by
respondents’ opinion about a key population rather
than access issues. This could be addressed by designing
question flows so that the opinion of HCWs can be
differentiated from that of community members.
Respondents could also be asked directly if answers are
based on personal experience.
Overall, sufficient time is needed to enable pilot testing
of the e-survey before its full launch to increase the
clarity and relevance of the questions. Moreover, a good
communication strategy, both during and after the
guidelines development process, is needed to ensure that
findings are clearly communicated and influence the
recommendations.rized reproduction of this article is prohibited.
Community and Service provider views to inform WHO ARV guidelines Hsieh et al. S215Although community values and preferences from this
consultation were generally considered in the guidelines
development process, the nature of such evidence was not
fully amenable to the GRADE methodology. Therefore,
to better inform operational and programmatic
recommendations of future guidelines, a more syste-
matic approach to gathering evidence of community
perspectives is needed, as well as a standardized way of
assessing the quality of this information. Communities
should also be involved early in the process. Ample time
should be provided to allow for substantive and nuanced
e-forums and FGDs, as well as increased community
mobilization for participation. Enabling the collection of
high-quality community data increases their credibility
and usefulness in the guidelines development process.
Implications
Ongoing communication and consultation with com-
munities and civil society members remains important
in the dissemination and implementation of the 2013
Guidelines, and national decision-making. The 2013
guidelines recommend a transparent and inclusive process
involving all stakeholders, including communities and
civil society, as a guiding principle of decision-making at
the national level [13]. Community and civil society
groups could assess how well their national HIV programs
are meeting the recommendations in the 2013 Guide-
lines, and use their analysis in discussions with govern-
ment and other key stakeholders to understand the gaps,
how to prioritize these areas, and how to work effectively
to improve ART access and retention in care. Further
work is needed to understand how to operationalize the
recommendation to increase task-shifting/sharing, such
as through consultation with community health workers
[13]. Finally, CBOs, NGOs, and networks have an
important role to play in incorporating some of the new
recommendations into their own programs to better
complement public healthcare services.
There is also a need for activities to enhance under-
standing of the new guidelines and treatment literacy
more broadly at the community level. For example, the
Community Guide on the Use of ART for Treatment and
Prevention, developed by GNPþ, STOP AIDS NOW!
and the Alliance, provides practical support for commu-
nities to engage in the national guidelines’ adaptation
processes [22]. Similarly, the International AIDS Society
is developing a code of good practice for clinicians and
HCWs [personal Communication between Edwin
Bernard (International AIDS Society, Consultant) and
Amy Hsieh on 24 October 2013] and the Community
Engagement Workgroup of the Interagency Task Team
on Prevention and Treatment of HIV Infection in
Pregnant Women, Mothers, and Children is developing
’ATreatment Literacy Guide for Pregnant Women Living
with HIV, Mothers, and Infant Caregivers’ to provide
individual-level guidance to those offered lifelong
treatment through Option Bþ [personal CommunicationCopyright © Lippincott Williams & Wilkins. Unautbetween Jessica Rodrigues (Interagency Task Team on
Prevention and Treatment of HIV Infection in Pregnant
Women, Mothers, and Children, Knowledge Manage-
ment) and Amy Hsieh on 19 November 2013]. It is
possible that many initiatives are being started to prepare
communities and HCWs to implement the guidelines.Conclusion
The findings of these community consultations have
reinforced the importance of community representation,
involvement, and participation in normative guidelines
development. For the effective scale up of ART
programs, it is critical to have a nuanced appreciation
for the different ways in which people interact with
certain services, and the role of communities and civil
society in service delivery.
The implications of the 2013 Guidelines for the
community of PLHIV, other key populations, and
community service providers are far reaching. The
2013 Guidelines provide guidance beyond clinical
recommendations, including recommendations on how
treatment can best be delivered in different contexts to
support access, adherence, and retention in care, most of
which resonated with the findings from community
consultations. In particular, the 2013 Guidelines call for a
greater community role in decision-making and imple-
mentation of national ART programs. The emphasis on
human rights, equity, and ethics [5] also provides
an opportunity for communities and civil society to
shape the way the guidelines are implemented. Effective
participation of communities to increase demand and
support for the delivery of community-based HIV
services requires investments to strengthen the capacity
of community groups and systems to ensure that they are
properly informed and fully engaged [18].Acknowledgements
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